Summary
The use of vasoactive intestinal peptide (VIP), sodium nitroprusside (SNP), and the reference combination of papaverine, prostaglandin E1, and phentolamine was studied in 22 adult cats. The maximal erectile response (intracavernous pressure, penile length, and rigidity) was produced by intracavernous injection of a combination of 1.65 mg papaverine, 0.5μg PGE1, and 25μg phentolamine. This combination was considered as “control” in order to compare the effect of other agents. VIP and SNP increased the intracavernous pressure and caused erection in a dose-dependent manner with a maximal response obtained with 5μg VIP or 10μg SNP. The duration of peak erection and the total duration of drug effect were significantly shorter with VIP and SNP than with the reference combination (P<0.01). Epinephrine (30μg) reversed the effects of SNP and significantly shortened the duration of peak action and total effect (P<0.05). This study supports the use of an in vivo feline model for the evaluation of vasoactive agents and demonstrates that the intracavernous injection of either VIP or SNP can induce penile erection in the adult cat.
Similar content being viewed by others
References
Aboseif SR, Breza J, Bosch RJLH et al. (1989) Local and systemic effects of chronic intracavernous injection of papaverine, prostaglandin E1, and saline in primates. J Urol 142:403
Abozeid M, Juenemann KP, Luo JA, Lue TF, Yen TSB, Tanagho EA (1987) Chronic papaverine treatment: the effect of repeated injections on the simian erectile response and penile tissue. J Urol 138:1263
Brindley GS (1983) Cavernosal alpha-blockage: a new technique for investigating and treating erectile impotence. Br J Psychiatry 143:332
Buvat J, Buvat-Herbaut M, Lemaire A, Marcolin G (1991) Reduced rate of fibrotic nodules in the cavernous bodies following auto-intracavernous injections of moxisylyte compared to papaverine. Int J Impotence Res 3:123
Crouch JE, Lackey MG (1969) Text-atlas of cat anatomy. Lea and Febiger, Philadelphia, p 160
Domer FR, Wessler G, Brown RL, Charles HC (1978) Involvement of the sympathetic nervous system in the urinary bladder internal sphincter and in penile erection in the anesthetized cat. Invest Urol 15:404
Hellstrom WJG, Wang R, Kadowitz P, Domer FR (1992) Potassium channel agonists cause penile erection in cats. Int J Impotence Res 4:27
Kielz EA, Blank MA, Bloom SR, Williams G (1987) Studies on intracavernosal VIP levels during pharmacologically induced penile erections. Br J Urol 59:334
Kielz EA, Bloom SR, Williams G (1989) Penile response to intracavernosal vasoactive intestinal polypeptide alone and in combination with other vasoactive agents. Br J Urol 64:191
Lomas GM, Jarow JP (1992) Risk factors for papaverine-induced priapism. J Urol 147:1280
Lue TF, Tanagho EA (1987) Physiology of erection and pharmacological management of impotence. J Urol 137:829
Padma-Nathan H (1990) The efficacy and synergy of polypharmacotherapy in primary and salvage therapy of vasculogenic erectile dysfunction. Int J Impotence Res 2 [Suppl 2]:257
Saenz de Tejada I, Goldstein I, Krane RJ (1988) Local control of penile erection: nerves, smooth muscle and endothelium. Urol Clin North Am 15:9
Saenz de Tejada I, Goldstein I, Azadzoi K, Krane RJ, Cohen RA (1989) Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence. N Engl J Med 320:1025
Sidi AA (1988) Vasoactive intracavernous pharmacotherapy. Urol Clin North Am 15:95
Virag R (1982) Intracavernous injection of papaverine for erectile failure. Lancet 2:938
Virag R, Frydman D, Legman M, Virag H (1984) Intracavernous injection of papaverine as a diagnostic and therapeutic method in erectile failure. Angiology 35:79
Weiske WH (1990) Prostaglandin E1 (PGE1) in diagnosis and treatment of erectile dysfunction (ED). Int J Impotence Res 2 [Suppl 2]:234
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wang, R., Higuera, T.R., Sikka, S.C. et al. Penile erections induced by vasoactive intestinal peptide and sodium nitroprusside. Urol. Res. 21, 75–78 (1993). https://doi.org/10.1007/BF00295198
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00295198